Article
Multiple-Allele MHC Class II Epitope Engineering by a Molecular Dynamics-Based Evolution Protocol.
Frontiers in immunology - 1 Jan 2022
Ochoa Rodrigo, Lunardelli Victoria Alves Santos, Rosa Daniela Santoro, Laio Alessandro, Cossio Pilar
Abstract excerpt
Epitopes that bind simultaneously to all human alleles of Major Histocompatibility Complex class II (MHC II) are considered one of the key factors for the development of improved vaccines and cancer immunotherapies. To engineer MHC II multiple-allele binders, we developed a protocol called PanMHC-PARCE, based on the unsupervised optimization of the epitope sequence by single-point mutations, parallel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
